Plain-English translation of NCT07513818 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether low-dose CT scans can be safely used to screen for lung cancer in current and former smokers. Researchers already know that these scans can find lung cancer at an early stage when it's easier to treat, but this study wants to make sure the screening works fairly and safely for all people in France.
While we know this screening method works to catch lung cancer early, this trial exists to figure out how to offer it to large groups of people fairly and safely, and to test whether artificial intelligence can help doctors read the scans accurately alongside human doctors.
You likely qualify if…
You likely don't qualify if…
You would receive three low-dose CT scans over two years: one at the start, one after one year, and one after two years. Each scan takes only a few minutes. If you are currently smoking, the study team will also offer you support to help you quit. Any nodules or suspicious findings will be managed according to current medical guidelines, and you'll receive follow-up care as needed.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
URC-CIC Paris Descartes Necker Cochin
Enrollment target
~20,000 participants
Started
May 2026
Primary completion
May 2031
Age range
50 Years – 74 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marie-Pierre REVEL, PhD
Assistance Publique - Hôpitaux de Paris
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.